Dicerna Pharmaceuticals, Inc., based in Cambridge, is a leading biopharmaceutical company specializing in utilizing ribonucleic acid interference RNAi technology to create innovative medicines.
The company's primary focus is on developing therapies that target and silence disease-causing genes, with the ultimate goal of improving patient outcomes and advancing the field of precision medicine.
Generated from their website's infomation